LT
LinkedIn

Linden Thomson, CFA

Senior Fund Manager | Biotechnology Fund | Oncology Fund

London, England, United Kingdom · 1 connection

Candriam

Not on Unlinked · Imported profile. Is this you? Claim it

About

I am the lead manager of the Candriam Biotechnology Fund and co-manage the Candriam Oncology Fund, with two decades of buy-side and sell-side experience as one of the early specialists in the biotechnology sector. In 2015, I was thrilled to be recognised in the ‘40 Under 40 Rising Stars of Asset Management’ and delighted to be a finalist for Fund Manager of the Year - Women In Investment Awards 2022 & 2023. My formative career was spent with Goldman Sachs where I established my deep technical expertise in the sector, developed the foundation for my framework in company analysis, context and investment opportunity, and built long-lasting relationships with the industry’s established and emerging leaders. I subsequently joined a biotech hedge fund at start-up stage, as a key member of the team that built and launched the fund from scratch. In 2011, I joined AXA IM Framlington. Over the 12 years I was there the Biotech Fund AuM and performance grew substantially, through a best-in-class investment framework, a network of sector experts spanning US / UK executives, analysts, investors, scientists, clinicians, and regulators, and the wealth of expertise that comes from managing the peak

Experience

Senior Fund Manager | Biotechnology Fund | Oncology FundCandriam
Feb 2024
Lead Manager, AXA IM Framlington Biotech Fund | Head, Healthcare Franchise | Member of the UK ExComAXA Investment Managers
Jun 2022
Lead Manager, AXA IM Framlington BioTech Fund | Head, Healthcare Franchise | Co-Head, Global EquityAXA Investment Managers
Jun 2011 to Jan 2023
Junior PartnerClear River Capital LLP
Jan 2009 to May 2011
Analyst/AssociateGoldman Sachs
Sep 2003 to May 2009

Education

The University of Edinburgh
Bachelor of Science - BS (Hons), Medical Microbiology
1999 to 2003